10 diagnostics reimbursement experts

Experience: Senior Director, Strategic Reimbursement · NeoGenomics Laboratories

Senior Director, Strategic Reimbursement at NeoGenomics Laboratories since 2016; the profile lists specialties in reimbursement and government affairs, healthcare medical policy, CMS and MACs, technology assessments, and coding, coverage and reimbursement. She was Global Director, Reimbursement, Healthcare Economics and Health Policy, Neuromodulation Division at St. Jude Medical (2013–2016) and Senior Director, Reimbursement Affairs, Government Healthcare Policy & Accreditation at Biomet (1994–2011).

Experience: Senior Vice President, Payer Strategy & Reimbursement · Myriad Genetics

Senior Vice President, Payer Strategy & Reimbursement at Myriad Genetics since January 2026. His other Myriad Genetics roles include Vice President, National Payer Markets (2021–2026), Director, Payer Markets and Reimbursement (2018–2021) and Senior Regional Account Manager (2013–2018); the profile describes market access work in the pharmaceutical and molecular diagnostic industries, including partnerships with managed care organizations and government accounts.

Experience: Vice President of Health Economics, Outcomes and Reimbursement · Pathnostics - A Diagnostics Solutions Company

Former Vice President of Health Economics, Outcomes and Reimbursement at Pathnostics - A Diagnostics Solutions Company (2019–2021) and VP Managed Care and Reimbursement at Caris Life Sciences (2016). She has been VP of Market Access at BillionToOne since 2021; the profile describes building, delivering and maintaining strategic reimbursement and payer relations plans.

Experience: Head of Market Access & Reimbursement · NeoGenomics Laboratories

Former Head of Market Access & Reimbursement at NeoGenomics Laboratories (2023–2024), and Chief Access Officer at Octave since February 2024. The profile says she secures CPT codes, reimbursement, medical policy coverage and commercial and governmental contracts, and describes market access work across molecular diagnostics, medical devices and other healthcare technologies.

Experience: Director - Payer Markets and Reimbursement · Myriad Genetics

Former Director - Payer Markets and Reimbursement at Myriad Genetics (2018–2024), and Vice President, Payer Markets there since February 2026 after serving as Sr. Director - Market Access (2024–2026). The profile describes shaping reimbursement and payer policy across precision medicine, oncology, women's health and mental health, and building payer value stories.

Experience: VP, Managed Care and Reimbursement · Genomic Health

Former VP, Managed Care and Reimbursement at Genomic Health (2011–2019) and Director of Reimbursement at RedPath Integrated Pathology (2010–2011). She was also VP Market Access at Exact Sciences (2019–2022) and Global Head of Market Access at Bionano (2022–2025), and has been Head of Strategy, Market Access at Natera since April 2025.

Experience: VP of Reimbursement & Payer Strategy · Foundation Medicine

Former VP of Reimbursement & Payer Strategy at Foundation Medicine (2012–2018). He has been Senior Vice President of Market Access at Belay Diagnostics since 2024, and was Senior Vice President of Market Access at GeneDx (2022–2023) and at Scipher Medicine (2019–2022) and Executive Vice President at CDx Diagnostics (2018–2019); the profile describes building and commercializing diagnostic tools.

Experience: Vice President Reimbursement · NavDx

Vice President Reimbursement at NavDx since April 2025, and Senior Director RCM and Payer Engagement there since 2023; the profile headline places the role at Naveris, Inc., which it describes as developing blood tests that identify viral cancers earlier than scans or biopsies. She was Senior Director Reimbursement Strategic Operations at Lucid Diagnostics (2023).

Experience: Senior Director Reimbursement · Adaptive Biotechnologies Corp.

Senior Director Reimbursement at Adaptive Biotechnologies Corp. since September 2025, where the profile says she oversees and manages the billing and reimbursement functions for Adaptive's CLIA lab service, working with physicians, payers and patients. She was Senior Director Billing Operations at CDx Diagnostics Inc. (2018–2025) and Senior Director, Revenue Cycle Management at Bio Reference Laboratories Inc - GeneDx (2015–2018).

Experience: Sr. Director of Reimbursement Revenue Cycle Management · Biotheranostics, Inc., A Hologic Company

Sr. Director of Reimbursement Revenue Cycle Management at Biotheranostics, Inc., A Hologic Company since 2016, and Director of Reimbursement Managed Care at Pathway Genomics Corporation (2015). The profile describes knowledge of medical billing and reimbursement processes and billing systems, including compliance, CCI and OIG regulations, MolDx and CMS.